Description

Epigenetics has evidenced an unparalleled growth during the past decade. A broad spectrum of applications and translation opportunities in several life sciences core markets depict the role of this discipline in medical advances. This study aims to cover the principal aspects associated with the current situation of epigenetics-related technology and its main trends and opportunities, especially associated with strategic portfolio management.